Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply
Open Access
- 30 October 2021
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (11) , 1-14
Abstract
In glucocorticoid (GC)-induced osteonecrosis of the femoral head (ONFH), downregulated osteogenic ability and damaged blood supply are two key pathogenic mechanisms. Studies suggested that cannabinoid receptor 2 (CB2) is expressed in bone tissue and it plays a positive role in osteogenesis. However, whether CB2 could enhance bone formation and blood supply in GC-induced ONFH remains unknown. In this study, we focused on the effect of CB2 in GC-induced ONFH and possible mechanisms in vitro and in vivo. By using GC-induced ONFH rat model, rat-bone mesenchymal stem cells (BMSCs) and human umbilical vein endothelial cells (HUVECs) to address the interaction of CB2 in vitro and in vivo, we evaluate the osteogenic and angiogenic effect variation and possible mechanisms. Micro-CT, histological staining, angiography, calcein labeling, Alizarin red staining (ARS), alkaline phosphatase (ALP), tartrate-resistant acid phosphatase (TRAP) staining, TUNEL staining, migration assay, scratch assay, and tube formation were applied in this study. Our results showed that selective activation of CB2 alleviates GC-induced ONFH. The activation of CB2 strengthened the osteogenic activity of BMSCs under the influence of GCs by promotion of GSK-3β/β-catenin signaling pathway. Furthermore, CB2 promoted HUVECs migration and tube-forming capacities. Our findings indicated that CB2 may serve as a rational new treatment strategy against GC-induced ONFH by osteogenesis activation and maintenance of blood supply.Keywords
This publication has 68 references indexed in Scilit:
- Disease modification of breast cancer–induced bone remodeling by cannabinoid 2 receptor agonistsJournal of Bone and Mineral Research, 2012
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Hypothalamic regulation of boneJournal of Molecular Endocrinology, 2010
- Regulation of Osteogenesis-Angiogenesis Coupling by HIFs and VEGFJournal of Bone and Mineral Research, 2009
- Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of actionThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesisProceedings of the National Academy of Sciences, 2009
- Cannabinoid-based drugs as anti-inflammatory therapeuticsNature Reviews Immunology, 2005
- Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.Journal of Clinical Investigation, 1998
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Necrosis of the femoral head in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1970